E&G Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.84M | Sell |
14,325
-10
| -0.1% | -$1.17K | 0.36% | 54 |
|
|
2026
Q1 | $1.72M | Buy |
14,335
+30
| +0.2% | +$3.46K | 0.38% | 55 |
|
|
2025
Q4 | $1.51M | Hold |
14,305
| – | – | 0.34% | 58 |
|
|
2025
Q3 | $1.2M | Sell |
14,305
-92
| -0.6% | -$7.58K | 0.28% | 70 |
|
|
2025
Q2 | $1.14M | Sell |
14,397
-201
| -1% | -$16K | 0.3% | 68 |
|
|
2025
Q1 | $1.31M | Sell |
14,598
-100
| -0.7% | -$9.34K | 0.37% | 59 |
|
|
2024
Q4 | $1.46M | Hold |
14,698
| – | – | 0.4% | 52 |
|
|
2024
Q3 | $1.67M | Buy |
14,698
+100
| +0.7% | +$11.9K | 0.46% | 43 |
|
|
2024
Q2 | $1.81M | Buy |
14,598
+80
| +0.6% | +$10.3K | 0.53% | 37 |
|
|
2024
Q1 | $1.91M | Buy |
14,518
+45
| +0.3% | +$5.55K | 0.6% | 34 |
|
|
2023
Q4 | $1.58M | Sell |
14,473
-900
| -6% | -$93.4K | 0.56% | 36 |
|
|
2023
Q3 | $1.58M | Hold |
15,373
| – | – | 0.58% | 39 |
|
|
2023
Q2 | $1.77M | Sell |
15,373
-200
| -1% | -$22.7K | 0.62% | 31 |
|
|
2023
Q1 | $1.66M | Buy |
15,573
+157
| +1% | +$17K | 0.61% | 35 |
|
|
2022
Q4 | $1.71M | Sell |
15,416
-760
| -5% | -$77.7K | 0.64% | 31 |
|
|
2022
Q3 | $1.39M | Sell |
16,176
-202
| -1% | -$18K | 0.51% | 38 |
|
|
2022
Q2 | $1.49M | Buy |
16,378
+110
| +0.7% | +$9.75K | 0.51% | 39 |
|
|
2022
Q1 | $1.33M | Hold |
16,268
| – | – | 0.36% | 63 |
|
|
2021
Q4 | $1.25M | Sell |
16,268
-91
| -0.6% | -$7.25K | 0.31% | 67 |
|
|
2021
Q3 | $1.23M | Buy |
+16,359
| New | +$1.24M | 0.33% | 64 |
|
|
2021
Q2 | – | Sell |
-17,144
| Closed | -$1.28M | – | 64 |
|
|
2021
Q1 | $1.26M | Buy |
17,144
+376
| +2% | +$27.7K | 0.37% | 62 |
|
|
2020
Q4 | $1.31M | Hold |
16,768
| – | – | 0.4% | 50 |
|
|
2020
Q3 | $1.33M | Buy |
16,768
+62
| +0.4% | +$4.86K | 0.46% | 46 |
|
|
2020
Q2 | $1.23M | Sell |
16,706
-513
| -3% | -$38.6K | 0.48% | 46 |
|
|
2020
Q1 | $1.26M | Sell |
17,219
-419
| -2% | -$32.9K | 0.62% | 31 |
|
|
2019
Q4 | $1.53M | Sell |
17,638
-11
| -0.1% | -$903 | 0.57% | 39 |
|
|
2019
Q3 | $1.42M | Buy |
17,649
+735
| +4% | +$58.9K | 0.57% | 43 |
|
|
2019
Q2 | $1.35M | Sell |
16,914
-625
| -4% | -$47.9K | 0.58% | 39 |
|
|
2019
Q1 | $1.39M | Sell |
17,539
-102
| -0.6% | -$7.63K | 0.61% | 39 |
|
|
2018
Q4 | $1.29M | Buy |
17,641
+1,261
| +8% | +$89K | 0.58% | 39 |
|
|
2018
Q3 | $1.11M | Buy |
16,380
+999
| +6% | +$63.6K | 0.42% | 60 |
|
|
2018
Q2 | $891K | Buy |
15,381
+1,680
| +12% | +$94.8K | 0.37% | 67 |
|
|
2018
Q1 | $712K | Sell |
13,701
-363
| -3% | -$19.6K | 0.31% | 78 |
|
|
2017
Q4 | $755K | Buy |
14,064
+419
| +3% | +$23.2K | 0.32% | 68 |
|
|
2017
Q3 | $834K | Buy |
13,645
+2,306
| +20% | +$140K | 0.38% | 61 |
|
|
2017
Q2 | $693K | Hold |
11,339
| – | – | 0.33% | 68 |
|
|
2017
Q1 | $688K | Sell |
11,339
-1,467
| -11% | -$89K | 0.35% | 69 |
|
|
2016
Q4 | $719K | Sell |
12,806
-1,566
| -11% | -$91.6K | 0.43% | 56 |
|
|
2016
Q3 | $856K | Sell |
14,372
-11,681
| -45% | -$683K | 0.5% | 49 |
|
|
2016
Q2 | $1.43M | Sell |
26,053
-2,825
| -10% | -$150K | 0.87% | 23 |
|
|
2016
Q1 | $1.46M | Sell |
28,878
-1,671
| -5% | -$81.8K | 0.95% | 24 |
|
|
2015
Q4 | $1.54M | Sell |
30,549
-6,912
| -18% | -$348K | 0.92% | 28 |
|
|
2015
Q3 | $1.76M | Buy |
37,461
+1,630
| +5% | +$86.6K | 1.12% | 23 |
|
|
2015
Q2 | $1.95M | Sell |
35,831
-2,343
| -6% | -$131K | 1.14% | 25 |
|
|
2015
Q1 | $2.09M | Sell |
38,174
-9,585
| -20% | -$543K | 1.24% | 21 |
|
|
2014
Q4 | $2.59M | Sell |
47,759
-5,560
| -10% | -$310K | 1.68% | 12 |
|
|
2014
Q3 | $3.02M | Buy |
53,319
+4
| +0% | +$225 | 1.94% | 11 |
|
|
2014
Q2 | $2.94M | Buy |
53,315
+3,463
| +7% | +$189K | 1.9% | 10 |
|
|
2014
Q1 | $2.7M | Buy |
49,852
+4,720
| +10% | +$244K | 2.13% | 8 |
|
|
2013
Q4 | $2.15M | Buy |
+45,132
| New | +$2.06M | 2.02% | 10 |
|
Other funds holding MRK
LMFP
ATO
QP
E&G Advisors's MRK Position: Q2 2026 in Review
E&G Advisors reduced its Merck (MRK) stake by 0.07% in Q2 2026, selling an estimated $1.17K and leaving 14,325 shares worth $1.84M. The position accounts for 0.36% of the portfolio, ranked #54.
E&G Advisors first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.02M in Q3 2014. 1,280 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- E&G Advisors held 14,325 shares of Merck worth $1.84M as of Q2 2026.
- E&G Advisors sold 10 Merck shares in Q2 2026, an estimated $1.17K.
- Merck made up 0.36% of E&G Advisors's portfolio in Q2 2026, its #54 holding.
- E&G Advisors first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
- E&G Advisors's Merck position peaked at $3.02M in Q3 2014.
- 1,280 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on E&G Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.